Iradimed (IRMD) Cash from Operations (2013 - 2026)

Iradimed (IRMD) has 14 years of Cash from Operations data on file, last reported at 8290000.0 in Q1 2026.

• On a quarterly basis, Cash from Operations rose 93.15% year-over-year to 8290000.0 in Q1 2026; TTM through Mar 2026 was 28945000.0, a 11.19% increase from a year earlier, with the FY2025 full-year figure at 24947000.0, down 2.64% from the prior year.
• Cash from Operations for Q1 2026 stood at 8290000.0, up from 5922572.0 in the prior quarter.
• Over the last five years, Cash from Operations for IRMD reached as high as 9115714.0 in Q3 2024 and fell as low as 1392684.0 in Q3 2023.
• Historically, Cash from Operations has averaged 4845219.0 across 5 years, with a median of 4292000.0 in 2025.
• Across the five-year window, Cash from Operations tumbled 64.64% in 2023 and soared 554.54% in 2024, its largest moves.
• Year by year, Cash from Operations stood at 3038844.0 in 2022, then rose by 28.75% to 3912480.0 in 2023, then soared by 53.01% to 5986606.0 in 2024, then declined by 1.07% to 5922572.0 in 2025, then jumped by 39.97% to 8290000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 8290000.0 in Q1 2026, 5922572.0 in Q4 2025, and 6986075.0 in Q3 2025.